PGM2L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.538200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.845400E-01
Normal-vs-Stage2
2.002000E-01
Normal-vs-Stage3
6.353800E-01
Normal-vs-Stage4
2.685800E-01
Stage1-vs-Stage2
1.538610E-01
Stage1-vs-Stage3
6.895400E-01
Stage1-vs-Stage4
2.322600E-01
Stage2-vs-Stage3
5.268000E-01
Stage2-vs-Stage4
7.314800E-01
Stage3-vs-Stage4
5.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.724200E-01
Normal-vs-AfricanAmerican
1.710230E-01
Normal-vs-Asian
3.831600E-01
Caucasian-vs-AfricanAmerican
5.994600E-01
Caucasian-vs-Asian
8.030400E-01
AfricanAmerican-vs-Asian
5.449800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.468400E-01
Normal-vs-Female
2.743000E-01
Male-vs-Female
7.603800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.614200E-01
Normal-vs-Age(41-60Yrs)
1.488240E-01
Normal-vs-Age(61-80Yrs)
2.820200E-01
Normal-vs-Age(81-100Yrs)
8.548000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.676600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.212400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.920600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.532390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.63549999999879E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.296300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.173800E-01
Normal-vs-Daily Drinker
3.693400E-01
Normal-vs-Weekly Drinker
3.532600E-01
Normal-vs-Occasional Drinker
1.504650E-01
Normal-vs-Social Drinker
3.057000E-01
Non Drinker-vs-Daily Drinker
9.205800E-01
Non Drinker-vs-Weekly Drinker
7.263800E-01
Non Drinker-vs-Occasional Drinker
4.117200E-01
Non Drinker-vs-Social Drinker
7.973000E-01
Daily Drinker-vs-Weekly Drinker
6.997000E-01
Daily Drinker-vs-Occasional Drinker
5.351200E-01
Daily Drinker-vs-Social Drinker
8.874800E-01
Weekly Drinker-vs-Occasional Drinker
2.736800E-01
Weekly Drinker-vs-Social Drinker
5.923000E-01
Occasional Drinker-vs-Social Drinker
6.521000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.418590E-01
Normal-vs-Grade 2
3.595600E-02
Normal-vs-Grade 3
1.964050E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.757270E-03
Grade 1-vs-Grade 3
1.677940E-03
Grade 1-vs-Grade 4
1.418590E-01
Grade 2-vs-Grade 3
9.637800E-01
Grade 2-vs-Grade 4
3.595600E-02
Grade 3-vs-Grade 4
1.964050E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.976600E-01
Normal-vs-NonDiabetic
2.486600E-01
Diabetic-vs-NonDiabetic
7.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.302620E-01
Normal-vs-NoPancreatitis
2.765600E-01
Pancreatitis-vs-NoPancreatitis
2.740000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.852400E-01
Normal-vs-N1
1.880190E-01
N0-vs-N1
5.072100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.173180E-01
Normal-vs-TP53-NonMutant
6.511200E-01
TP53-Mutant-vs-TP53-NonMutant
3.8033999999465E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
